155 related articles for article (PubMed ID: 1205813)
1. Proceedings: Neonatal diagnosis of maple syrup urine disease and the influence of exchange blood transfusion.
Russell A; Statter M; Shina A; Perlman M
Isr J Med Sci; 1975 Nov; 11(11):1218-9. PubMed ID: 1205813
[No Abstract] [Full Text] [Related]
2. [Disorders of leucine, isoleucine and valine metabolism (maple syrup urine disease)].
Vulović D; Vilhar N; Hajduković R; Marjanović B; Stojanović Lj
Srp Arh Celok Lek; 1975 May; 103(5):419-36. PubMed ID: 1188483
[No Abstract] [Full Text] [Related]
3. [Neonatal diagnosis of maple syrup urine disease and trial of exchange transfusion].
Statter M; Ben-Zvi A; Russell A
Harefuah; 1976 Oct; 91(7):167-9. PubMed ID: 1002028
[No Abstract] [Full Text] [Related]
4. [A case of maple syrup disease. Clinical and electroencephalographic observations with dietetic experiment. Critical review of literature].
Grossi-Bianchi ML; Gatti R; Marchi AG
Minerva Pediatr; 1967 Aug; 19(33):1552-65. PubMed ID: 4889027
[No Abstract] [Full Text] [Related]
5. [Studies on "branched chain oxoacid aciduria" (maple syrup diseases)].
Goedde HW; Blume KG; Möhlenbeck F; Rotthauwe HW; Simon HA; Lang K
Med Klin; 1966 Dec; 61(52):2063-7. PubMed ID: 4385693
[No Abstract] [Full Text] [Related]
6. [Biochemical-genetic studies in maple syrup disease].
Goedde HW; Blume KG
Med Welt; 1968 Dec; 49():2699-703. PubMed ID: 5730703
[No Abstract] [Full Text] [Related]
7. M aple syrup urine disease. A review with a report of an additional case.
Schwartz JF; Kolendrianos ET
Dev Med Child Neurol; 1969 Aug; 11(4):460-70. PubMed ID: 5805351
[No Abstract] [Full Text] [Related]
8. [Metabolic study of the classic form of leucinosis during exchange transfusion therapy].
Zeman J; Hyánek J; Houstková H; Rubín A; Verner P; Pehal F; Konecná L; Zapadlo M; Plavka R; Wendel U
Cesk Pediatr; 1987 Apr; 42(4):219-22. PubMed ID: 3594613
[No Abstract] [Full Text] [Related]
9. [Compliance of the diet restricted with leucine, isoleucine and valine in maple syrup urine disease (MSUD) children].
Kowalik A; Narojek L; Sykut-Cegielska J
Rocz Panstw Zakl Hig; 2007; 58(1):95-101. PubMed ID: 17711097
[TBL] [Abstract][Full Text] [Related]
10. Clinical consequences of disorders in the intermediate metabolism of branched chain amino acids (valine, leucine and isoleucine).
Mogoş T; Cheţa CP; Mincu IT
Rom J Intern Med; 1994; 32(1):57-61. PubMed ID: 8081313
[TBL] [Abstract][Full Text] [Related]
11. [3 patients with maple syrup urine disease].
Merinero B; del Valle JA; García MJ; García Miguel MJ; Barrio MI; García Hortelano J; Morales E; González F; García Aparicio J; Sáez Pérez E
An Esp Pediatr; 1983 Nov; 19(5):393-400. PubMed ID: 6660657
[TBL] [Abstract][Full Text] [Related]
12. [Clinico-metabolic aspects of maple syrup urine disease and manifestation of some new trophometabolic relationships].
Popa W; Apostolescu I; Popescu G
Pediatria (Bucur); 1970; 19(1):51-6. PubMed ID: 5419930
[No Abstract] [Full Text] [Related]
13. [Dietetics in hereditary enzyme deficiencies].
Royer P
Sem Hop; 1970 Feb; 46(10):653-9. PubMed ID: 4314674
[No Abstract] [Full Text] [Related]
14. Maple syrup urine disease. Two cases in Israel.
Chemke J; Levin S
Isr J Med Sci; 1975 Aug; 11(8):809-16. PubMed ID: 1165176
[TBL] [Abstract][Full Text] [Related]
15. MAPLE SYRUP URINE DISEASE, WITH PARTICULAR REFERENCE TO DIETOTHERAPY.
SNYDERMAN SE; NORTON PM; ROITMAN E; HOLT LE
Pediatrics; 1964 Oct; 34():454-72. PubMed ID: 14212461
[No Abstract] [Full Text] [Related]
16. Multiple exchange transfusions as treatment during the acute period in maple syrup urine disease.
Schuchmann L; Witt I; Schulz P; Schumacher H; Rüdiger H
Helv Paediatr Acta; 1972 Sep; 27(4):449-56. PubMed ID: 4644280
[No Abstract] [Full Text] [Related]
17. Prospective study of maple-syrup-urine disease for the first four days of life.
DiGeorge AM; Rezvani I; Garibaldi LR; Schwartz M
N Engl J Med; 1982 Dec; 307(24):1492-5. PubMed ID: 7144815
[No Abstract] [Full Text] [Related]
18. The need of essential amino acids in children. An evaluation based on the intake of phenylalanine, tyrosine, leucine, isoleucine, and valine in children with phenylketonuria, tyrosine amino transferase defect, and maple syrup urine disease.
Kindt E; Halvorsen S
Am J Clin Nutr; 1980 Feb; 33(2):279-86. PubMed ID: 6101930
[TBL] [Abstract][Full Text] [Related]
19. [Neonatal leucinosis with favourable course. Therapeutic problems].
Astruc J; Froye E; Luciani JM; Bellet H; Magnan de Bornier P; Brunel D
Ann Pediatr (Paris); 1977 Sep; 24(8-9):605-10. PubMed ID: 16211914
[No Abstract] [Full Text] [Related]
20. [Maple syrup urine disease].
Incesu L; Tasdemir HA; Yazicioglu AK; Belet U; Danaci M
Radiol Med; 2001 Sep; 102(3):194-6. PubMed ID: 11677467
[No Abstract] [Full Text] [Related]
[Next] [New Search]
